Delivery Order SPE2DB22D9239-SPE2DB23FDK70
Award Date 7/6/23
Potential Completion Date 7/27/23
Potential Value $77K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DOD) awarded a $8,527 delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The firm fixed price order is being carried out under the prime contractor DMS Pharmaceutical Group Inc. in Park Ridge, Illinois, running from September 29, 2023 through October 23, 2023. No set aside designation or subcontractors were indicated. The DLA supports military readiness by procuring and providing logistics support for medical...
- The Defense Logistics Agency (DOD) awarded a $4,642.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for XOLAIR 150 MG/ML SYRINGEML. The place of performance is Park Ridge, Illinois. The start date is July 6, 2023 and the end date is July 27, 2023. No set aside designation or subcontractors are indicated. The DLA procures and provides logistics support for medical supplies and equipment for the Department of Defense and other federal agencies, so this order is likely...
- The Defense Logistics Agency (DOD) awarded a $77,370 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for XOLAIR 150 MG/ML SYRINGEML. The place of performance is Park Ridge, Illinois. The period of performance is from September 5, 2023 through September 26, 2023. As the DLA supports the logistical needs of the military services, this delivery order is likely providing a pharmaceutical product in support of DOD medical readiness programs over the three week period of...
- The Defense Logistics Agency awarded a delivery order valued at $69,633 to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The contract will be performed in Park Ridge, Illinois over a period of three weeks concluding on August 29, 2023. It utilizes a firm fixed price contract type. No subcontractors or set aside designations were indicated. The Defense Logistics Agency supports America's armed forces by providing supplies in healthcare, construction and...
- The Defense Logistics Agency awarded a $11,605.50 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4561367155 XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML. The contract will be performed in Park Ridge, Illinois between June 26, 2023 and July 18, 2023. As the DLA supports the Department of Defense by procuring food, clothing, medicines, fuel and other necessary supplies, this delivery order will provide the military with Xolair, a medication used to treat asthma and chronic idiopathic...
- The Defense Logistics Agency (DOD) awarded a $3,094.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the purchase of XOLAIR 150 MG/ML SYRINGEML. The place of performance is Park Ridge, Illinois. The period of performance is from August 29, 2023 through September 20, 2023. No set aside designation or subcontractors were identified. The DLA supports military readiness by procuring and providing supplies, equipment, and weapon systems for the armed forces and other government...
- The Defense Logistics Agency, a combat support agency within the Department of Defense, awarded a $46,422 delivery order to DMS Pharmaceutical Group Inc. for Xolair 150 mg/ml syringes. The firm fixed price order is for product delivery to a location in Park Ridge, Illinois between July 3rd and July 25th, 2023. Xolair is a medication used to treat certain allergic conditions and asthma. As the DLA supports military operations by providing food, fuel, medicines and other supplies, this order for...
- The Defense Logistics Agency (DOD) awarded a $1,547 delivery order to DMS Pharmaceutical Group Inc. for Xolair 150 MG/ML syringes. The firm fixed price order is for product delivery to a location in Park Ridge, Illinois between August 15 and September 6, 2023. Xolair is used to treat allergic conditions like asthma. This order was placed under an existing DLA pharmaceutical supply contract vehicle to procure needed medications for DOD personnel and their families. No set aside designation or...
- The Defense Logistics Agency (DOD) awarded a $4,642.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The place of performance will be in Park Ridge, Illinois. The period of performance is from September 20, 2023 through October 12, 2023. No set aside designation or subcontractors were identified. The DLA supports military readiness by procuring and providing logistics support for medical supplies and pharmaceuticals. This...
- The Defense Logistics Agency awarded a delivery order valued at $11,605.50 to DMS Pharmaceutical Group Inc. to supply Xolair 75 MG/0.5 ML syringes. The firm fixed price order is for the delivery of 0.5mL syringes of Xolair to a location in Park Ridge, Illinois. Performance will take place between August 1st and August 22nd, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support all military services and combatant commands. This...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB23FDK70Delivery Order
The Defense Logistics Agency (DOD) awarded a $77,370 delivery order to DMS Pharmaceutical Group Inc. for XOLAIR 150 MG/ML SYRINGEML. The firm fixed price order is being performed in Park Ridge, Illinois under contract number 4561452920 from July 6th to July 27th, 2023. No set aside designation or subcontractors were identified. The DLA supports military readiness by procuring and providing logistics support for medical supplies, likely including this order for the injectable medication Xolair used to treat allergic conditions like asthma.
Generated 12/15/23, 11:12 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $77.4k | 7/6/23 |